Diagnostic Imaging Drug Development Expertise
From lab to market
We provide full-service Imaging Diagnostics Clinical Development, from pre-clinical to IND and NDA submission and Medical Affairs.
We have developed current market leaders
We have led 7 imaging new drug approvals globally: MRI, CT, and radiopharmaceuticals.
Literature-based approvals
Utilizing only existing literature reviews, we have gained 5 new indications for imaging drugs without performing additional clinical trials.
Over 40 years of experience
Between our two RadMD principals, there are over 40 years of contrast agent development experience.
Imaging management solutions
Our full-service imaging management solutions provide a comprehensive set of services to support pharmaceutical, medical device and AI companies with their clinical trials.
Our reader group
We are the global leader in providing consultants to perform imaging BICR (blinded independent central reviews)
Diagnostic Imaging Drug Development Expertise
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
We have 12 years of experience in comprehensive sourcing and management of our readers for over 600 trials.